NCT03404726
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03404726
Title A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Montefiore Medical Center The Bronx New York 10467-2490 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
Institut Gustave Roussy Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field